U.S. Markets closed
  • S&P 500

    4,401.46
    -20.84 (-0.47%)
     
  • Dow 30

    35,058.52
    -85.79 (-0.24%)
     
  • Nasdaq

    14,660.58
    -180.14 (-1.21%)
     
  • Russell 2000

    2,191.83
    -25.09 (-1.13%)
     
  • Crude Oil

    71.97
    +0.32 (+0.45%)
     
  • Gold

    1,799.10
    -0.70 (-0.04%)
     
  • Silver

    24.73
    +0.08 (+0.33%)
     
  • EUR/USD

    1.1822
    -0.0004 (-0.0355%)
     
  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     
  • Vix

    19.36
    +1.78 (+10.13%)
     
  • GBP/USD

    1.3882
    +0.0003 (+0.0236%)
     
  • USD/JPY

    109.7750
    +0.0080 (+0.0073%)
     
  • BTC-USD

    39,023.96
    +1,666.03 (+4.46%)
     
  • CMC Crypto 200

    898.78
    +22.55 (+2.57%)
     
  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     
  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

LAWSUITS FILED AGAINST PCT, PRVB and WPG - Jakubowitz Law Pursues Shareholders Claims

·3 min read

NEW YORK, NY / ACCESSWIRE / May 26, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

PureCycle Technologies, Inc. (NASDAQ:PCT)

CONTACT JAKUBOWITZ ABOUT PCT:
https://claimyourloss.com/securities/purecycle-technologies-inc-loss-submission-form/?id=16211&from=1

Class Period : November 16, 2020 - May 5, 2021

Lead Plaintiff Deadline : July 12, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (iii) PureCycle's financial projections are baseless; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Provention Bio, Inc. (NASDAQ:PRVB)

CONTACT JAKUBOWITZ ABOUT PRVB:
https://claimyourloss.com/securities/provention-bio-inc-loss-submission-form/?id=16211&from=1

Class Period : November 2, 2020 - April 8, 2021

Lead Plaintiff Deadline : July 20, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the teplizumab Biologics License Application ("BLA") was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA's approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Washington Prime Group, Inc. (NYSE:WPG)

CONTACT JAKUBOWITZ ABOUT WPG:
https://claimyourloss.com/securities/washington-prime-group-inc-loss-submission-form/?id=16211&from=1

Class Period : November 5, 2020 - March 4, 2021

Lead Plaintiff Deadline : July 23, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) WPG's financial condition was deteriorating substantially; (2) as a result, there was substantial uncertainty about the Company's ability to meet its capital structure obligations as they became due; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/649163/LAWSUITS-FILED-AGAINST-PCT-PRVB-and-WPG--Jakubowitz-Law-Pursues-Shareholders-Claims